Synthetic cathinone abuse

References

• US Department of Justice National Drug Intelligence CenterSituation report: Synthetic cathinones (bath salts) – an emerging domestic threat2011 Available from: http://www.justice.gov/archive/ndic/pubs44/44571/44571p.pdfAccessed December 10, 2012
   Google Scholar
• KalixPBraendenOPharmacological aspects of the chewing of khat leavesPharmacol Rev19853721491642864707
   PubMed Web of Science ®Google Scholar
• [No authors listed]Review of the pharmacology of khat. Report of a WHO advisory groupBull Narc198032383936266563
   PubMedGoogle Scholar
• SzendreiKThe chemistry of khatBull Narc19803235356911031
   PubMedGoogle Scholar
• United NationsStudies on the chemical composition of khat. III. Investigations on the phenylalkylamine fraction UN document MNAR/11/1975
   Google Scholar
• PetersonDWMaitaiCKSparberSBRelative potencies of two phenylalkylamines found in the abused plant Catha edulis, khatLife Sci19802722214321476111010
   PubMed Web of Science ®Google Scholar
• BerrangBDLewinAHCarrollFIEnantiomeric alpha-aminopropiophenones (cathinone): preparation and investigationJ Org Chem1982471326432647
   Web of Science ®Google Scholar
• LuqmanWDanowskiTSThe use of khat (Catha edulis) in Yemen. Social and medical observationsAnn Intern Med1976852246249942147
   PubMed Web of Science ®Google Scholar
• DarganPIAlbertSWoodDMMephedrone use and associated adverse effects in school and college/university students before the UK legislation changeQJM20101031187587920675396
   PubMed Web of Science ®Google Scholar
• KellyJPCathinone derivatives: a review of their chemistry, pharmacology and toxicologyDrug Test Anal201137–843945321755607
   PubMed Web of Science ®Google Scholar
• GlennonRAYoungRMartinBRDal CasonTAMethcathione (“cat”): an enantiomeric potency comparisonPharmacol Biochem Behav19955046016067617707
   PubMed Web of Science ®Google Scholar
• Galvan-ArzateSSantamariaANeurotoxicity of diethylpropion: neurochemical and behavioral findings in ratsAnn N Y Acad Sci200296521422412105097
   PubMed Web of Science ®Google Scholar
• GardosGColeJOEvaluation of pyrovalerone in chronically fatigued volunteersCurr Ther Res Clin Exp197113106316354402508
   PubMed Web of Science ®Google Scholar
• Advisory Council on the Misuse of DrugsACMD report on the consideration of the cathinones2010 Available from: http://www.homeoffice.gov.uk/acmd1/acmd-cathinodes-report-2010?view=BinaryAccessed November 1, 2012
   Google Scholar
• CoppolaMMondolaRSynthetic cathinones: chemistry, pharmacology and toxicology of a new class of designer drugs of abuse marketed as “bath salts” or “plant food.”Toxicol Lett2012211214414922459606
   PubMed Web of Science ®Google Scholar
• JamesDAdamsRDSpearsRClinical characteristics of mephedrone toxicity reported to the UK National Poisons Information ServiceEmerg Med J201128868668920798084
   PubMed Web of Science ®Google Scholar
• ThorntonSLGeronaRRTomaszewskiCAPsychosis from a bath salt product containing flephedrone and MDPV with serum, urine, and product quantificationJ Med Toxicol20128331031322528592
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention (CDC)Emergency department visits after use of a drug sold as “bath salts” – Michigan, November 13, 2010–March 31, 2011MMWR Morb Mortal Wkly Rep2011601962462721597456
   PubMedGoogle Scholar
• SpillerHARyanMLWestonRGJansenJClinical experience with and analytical confirmation of “bath salts” and “legal highs” (synthetic cathinones) in the United StatesClin Toxicol2011496499505
   PubMed Web of Science ®Google Scholar
• DickDTorranceCMixmag drugs surveyMixmag20102254453
   Google Scholar
• American Association of Poison Control Centers (AAPCC)Bath salts data2012 Available from: https://aapcc.s3.amazonaws.com/files/library/Bath_Salts_Data_for_Website_1.09.2013.pdfAccessed December 15, 2012
   Google Scholar
• Drug Enforcement AdministrationSpecial Report: Synthetic Cannabinoids and Synthetic Cathinones Reported in NFLIS, 2009–2010Springfield (VA)DEA2011 Available from: http://www.deadiversion.usdoj.gov/nflis/2010rx_synth.pdfAccessed December 10, 2012
   Google Scholar
• DarganPISedefovRGallegosAWoodDMThe pharmacology and toxicology of the synthetic cathinone mephedrone (4-methylmethcathinone)Drug Test Anal201137–845446321755604
   PubMed Web of Science ®Google Scholar
• ReganLMitchelsonMMacdonaldCMephedrone toxicity in a Scottish emergency departmentEmerg Med J201128121055105821183522
   PubMed Web of Science ®Google Scholar
• Drug Enforcement AdministrationSchedules of controlled substances: placement of ezogabine into Schedule V. Final ruleFed Regist201176241778957789922175093
   PubMedGoogle Scholar
• KalixPCathinone, a natural amphetaminePharmacol Toxicol199270277861508843
   PubMedGoogle Scholar
• ToennesSWHarderSSchrammMNiessCKauertGFPharmacokinetics of cathinone, cathine and norephedrine after the chewing of khat leavesBr J Clin Pharmacol200356112513012848785
   PubMed Web of Science ®Google Scholar
• WidlerPMathysKBrenneisenRKalixPFischHUPharmacodynamics and pharmacokinetics of khat: a controlled studyClin Pharmacol Ther19945555565627910126
   PubMed Web of Science ®Google Scholar
• BrenneisenRFischHUKoelbingUGeisshuslerSKalixPAmphetamine-like effects in humans of the khat alkaloid cathinoneBr J Clin Pharmacol19903068258282288828
   PubMed Web of Science ®Google Scholar
• GuantaiANMaitaiCKMetabolism of cathinone to d-norpseudoephedrine in humansJ Pharm Sci19837210121712186644577
   PubMed Web of Science ®Google Scholar
• ToennesSWKauertGFExcretion and detection of cathinone, cathine, and phenylpropanolamine in urine after kath chewingClin Chem200248101715171912324488
   PubMed Web of Science ®Google Scholar
• KalixPPharmacological properties of the stimulant khatPharmacol Ther19904833974161982180
   PubMed Web of Science ®Google Scholar
• MeyerMRWilhelmJPetersFTMaurerHHBeta-keto amphetamines: studies on the metabolism of the designer drug mephedrone and toxicological detection of mephedrone, butylone, and methylone in urine using gas chromatography-mass spectrometryAnal Bioana Chem2010397312251233
   PubMed Web of Science ®Google Scholar
• ZaitsuKKatagiMKamataHTDetermination of the metabolites of the new designer drugs bk-MBDB and bk-MDEA in human urineForensic Sci Int20091881–313113919406592
   PubMed Web of Science ®Google Scholar
• KamataHTShimaNZaitsuKMetabolism of the recently encountered designer drug, methylone, in humans and ratsXenobiotica200636870972316891251
   PubMed Web of Science ®Google Scholar
• MeyerMRDuPSchusterFMaurerHHStudies on the metabolism of the alpha-pyrrolidinophenone designer drug methylenedioxy-pyrovalerone (MDPV) in rat and human urine and human liver microsomes using GC-MS and LC-high-resolution MS and its detectability in urine by GC-MSJ Mass Spectrom201045121426144221053377
   PubMed Web of Science ®Google Scholar
• MeyerMRVollmarCSchwaningerAEWolfEMaurerHHNew cathinone-derived designer drugs 3-bromomethcathinone and 3-fluoromethcathinone: studies on their metabolism in rat urine and human liver microsomes using GC-MS and LC-high-resolution MS and their detectability in urineJ Mass Spectrom201247225326222359337
   PubMed Web of Science ®Google Scholar
• KhreitOIGrantMHZhangTHendersonCWatsonDGSutcliffeOBElucidation of the phase I and phase II metabolic pathways of (+/−)-4′-methylmethcathinone (4-MMC) and (+/−)-4′-(trifluoromethyl) methcathinone (4-TFMMC) in rat liver hepatocytes using LC-MS and LC-MS(2)J Pharm Biomed Anal20137217718522985528
   PubMed Web of Science ®Google Scholar
• PawlikEPlässerGMahlerHDaldrupTStudies on the phase I metabolism of the new designer drug 3-fluoromethcathinone using rabbit liver slicesInt J Legal Med2012126223124021785905
   PubMed Web of Science ®Google Scholar
• MuellerDMRentschKMGeneration of metabolites by an automated online metabolism method using human liver microsomes with subsequent identification by LC-MS(n), and metabolism of 11 cathinonesAnal Bioanal Chem201240262141215122231510
   PubMed Web of Science ®Google Scholar
• Psychonaut WebMapping Research GroupMephedrone ReportLondonInstitute of Psychiatry, King’s College London2009
   Google Scholar
• NewcombeRMephedrone: The Use of Mephedrone (M-cat, Meow) in MiddlesbroughManchesterLifeline Publications and Research2009
   Google Scholar
• GibbonsSZlohMAn analysis of the ‘legal high’ mephedroneBioorg Med Chem Lett201020144135413920542690
   PubMed Web of Science ®Google Scholar
• SimmlerLDBuserTADonzelliMPharmacological characterization of designer cathinones in vitroBr J Pharmacol2013168245847022897747
   PubMed Web of Science ®Google Scholar
• CozziNVSievertMKShulginATJacobP3rdRuohoAEInhibition of plasma membrane monoamine transporters by beta-ketoamphetaminesEur J Pharmacol19993811636910528135
   PubMed Web of Science ®Google Scholar
• Lopez-ArnauRMartinez-ClementeJPubillDEscubedoECamarasaJComparative neuropharmacology of three psychostimulant cathinone derivatives: butylone, mephedrone and methyloneBr J Pharmacol2012167240742022509960
   PubMed Web of Science ®Google Scholar
• WoodDMGreeneSLDarganPIClinical pattern of toxicity associated with the novel synthetic cathinone mephedroneEmerg Med J201128428028220581379
   PubMed Web of Science ®Google Scholar
• KehrJIchinoseFYoshitakeSMephedrone, compared with MDMA (ecstasy) and amphetamine, rapidly increases both dopamine and 5-HT levels in nucleus accumbens of awake ratsBr J Pharmacol201116481949195821615721
   PubMed Web of Science ®Google Scholar
• DaviesSWoodDMSmithGPurchasing ‘legal highs’ on the Internet – is there consistency in what you get?QJM2010103748949320413562
   PubMed Web of Science ®Google Scholar
• European Monitoring Centre for Drugs and Drug AddictionReport on the Risk Assessment of Mephedrone in the framework of the Council Decision on New Psychoactive SubstancesLisbonEMCDDA2011
   Google Scholar
• SauerCHoffmannKSchimmelUPetersFTAcute poisoning involving the pyrrolidinophenone-type designer drug 4′-methyl-alpha-pyrrolidinohexanophenone (MPHP)Forensic Sci Int20112081–3e20e2521444164
   PubMed Web of Science ®Google Scholar
• BruntTMPoortmanANiesinkRJvan den BrinkWInstability of the ecstasy market and a new kid on the block: mephedroneJ Psychopharmacol201125111543154720826554
   PubMed Web of Science ®Google Scholar
• Al-MotarrebABrianconSAl-JaberNKhat chewing is a risk factor for acute myocardial infarction: a case-control studyBr J Clin Pharmacol200559557458115842556
   PubMed Web of Science ®Google Scholar
• BalintEEFalkayGBalintGAKhat – a controversial plantWien Klin Wochenschr200912119–2060461419921126
   PubMed Web of Science ®Google Scholar
• ForresterMBSynthetic cathinone exposures reported to Texas poison centersAm J Drug Alcohol Abuse201238660961522541001
   PubMed Web of Science ®Google Scholar
• BorekHAHolstegeCPHyperthermia and multiorgan failure after abuse of “bath salts” containing 3,4-methylenedioxypyrovaleroneAnn Emerg Medicine2012601103105
   PubMed Web of Science ®Google Scholar
• SammlerEMFoleyPLLauderGDWilsonSJGoudieARO’RiordanJIA harmless high?Lancet2010376974274220801405
   PubMed Web of Science ®Google Scholar
• IqbalMMonaghanTRedmondJManganese toxicity with ephedrone abuse manifesting as parkinsonism: a case reportJ Med Case Rep2012615222313512
   PubMedGoogle Scholar
• YildirimEAEsşsizoğluAKöksalADoğuBBaybasşSGökalpP[Chronic manganese intoxication due to methcathinone (ephedron) abuse: a case report]Turk Psikiyatri Derg2009203294298 Turkish19757228
   PubMed Web of Science ®Google Scholar
• EllisonGNeural degeneration following chronic stimulant abuse reveals a weak link in brain, fasciculus retroflexus, implying the loss of forebrain control circuitryEur Neuropsychopharmacol200212428729712126867
   PubMed Web of Science ®Google Scholar
• PuertaEHerviasIAguirreNOn the mechanisms underlying 3,4-methylenedioxymethamphetamine toxicity: the dilemma of the chicken and the eggNeuropsychobiology2009603–411912919893329
   PubMed Web of Science ®Google Scholar
• den HollanderBRozovSLindenAMUusi-OukariMOjanperaIKorpiERLong-term cognitive and neurochemical effects of “bath salt” designer drugs methylone and mephedronePharmacol Biochem Behav2012103350150923099177
   PubMed Web of Science ®Google Scholar
• MixmagMixmag’s drug survey: the results2012 Available from: http://www.mixmag.net/drugssurveyAccessed December 1, 2012
   Google Scholar
• Van HoutMCBinghamT“A costly turn on”: patterns of use and perceived consequences of mephedrone based head shop products amongst Irish injectorsInt J Drug Policy201223318819722342322
   PubMed Web of Science ®Google Scholar
• WoodDMDaviesSGreeneSLCase series of individuals with analytically confirmed acute mephedrone toxicityClin Toxicol2010489924927
   PubMed Web of Science ®Google Scholar
• PearsonJMHargravesTLHairLSThree fatal intoxications due to methyloneJ Anal Toxicol201236644445122589523
   PubMed Web of Science ®Google Scholar
• AdamowiczPTokarczykBStanaszekRSlopiankaMFatal mephedrone intoxication – a case reportJ Anal Toxicol2013371374223134715
   PubMed Web of Science ®Google Scholar
• WoodDMDaviesSPuchnarewiczMRecreational use of mephedrone (4-methylmethcathinone, 4-MMC) with associated sympathomimetic toxicityJ Med Toxicol20106332733020358417
   PubMedGoogle Scholar
• MurrayBLMurphyCMBeuhlerMCDeath following recreational use of designer drug “bath salts” containing 3,4-methylenedioxypyrovalerone (MDPV)J Med Toxicol201281697522271565
   PubMedGoogle Scholar
• DerungsASchietzelSMeyerMRMaurerHHKrahenbuhlSLiechtiMESympathomimetic toxicity in a case of analytically confirmed recreational use of naphyrone (naphthylpyrovalerone)Clin Toxicol2011497691693
   PubMed Web of Science ®Google Scholar